ZBTB16 and neoplasm: In line with the in vitro results, ZBTB16 and PPARγ, RXRα protein levels were both increased (Fig. 8J, K), which confirmed that PPI effectively inhibits tumor growth by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway.